Synthesis and 11 beta hydroxysteroid dehydrogenase 1 inhibition of thiazolidine derivatives with an adamantyl group
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwon, Sung Wook | - |
dc.contributor.author | Kang, Seung Kyu | - |
dc.contributor.author | Lee, Jae Hong | - |
dc.contributor.author | Bok, Joo Hwan | - |
dc.contributor.author | Kim, Chi Hyun | - |
dc.contributor.author | Rhee, Sang Dal | - |
dc.contributor.author | Jung, Won Hoon | - |
dc.contributor.author | Kim, Hee Youn | - |
dc.contributor.author | Bae, Myung Ae | - |
dc.contributor.author | Song, Jin Sook | - |
dc.contributor.author | Ha, Duck Chan | - |
dc.contributor.author | Cheon, Hyae Gyoung | - |
dc.contributor.author | Kim, Ki Young | - |
dc.contributor.author | Ahn, Jin Hee | - |
dc.date.accessioned | 2021-09-07T16:25:33Z | - |
dc.date.available | 2021-09-07T16:25:33Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2011-01 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/113329 | - |
dc.description.abstract | A new series of thiazolidine derivatives with an adamantyl group was synthesized and evaluated for their ability to inhibit 11 beta-hydroxysteroid dehydrogenase 1 (11 beta-HSD1). Our initial compound 5a showed a weak inhibitory activity. Significant improvements in potency were achieved by substituent modification. The potent compound 8g (E) showed good in vitro inhibitory activity toward human 11 beta-HSD1, selectivity toward 11 beta-HSD2, metabolic stability, pharmacokinetic, and safety profile. Furthermore, this compound significantly inhibited 11 beta-HSD1 activity in rat and monkey models, and showed improved glycemic control in KKAy mice. (c) 2010 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | 11-BETA-HYDROXYSTEROID DEHYDROGENASE | - |
dc.subject | METABOLIC SYNDROME | - |
dc.subject | VISCERAL OBESITY | - |
dc.subject | TYPE-1 | - |
dc.subject | MICE | - |
dc.subject | HYPERGLYCEMIA | - |
dc.subject | DRUGS | - |
dc.title | Synthesis and 11 beta hydroxysteroid dehydrogenase 1 inhibition of thiazolidine derivatives with an adamantyl group | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ha, Duck Chan | - |
dc.identifier.doi | 10.1016/j.bmcl.2010.10.123 | - |
dc.identifier.scopusid | 2-s2.0-78650509855 | - |
dc.identifier.wosid | 000285544400089 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.21, no.1, pp.435 - 439 | - |
dc.relation.isPartOf | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 21 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 435 | - |
dc.citation.endPage | 439 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | 11-BETA-HYDROXYSTEROID DEHYDROGENASE | - |
dc.subject.keywordPlus | METABOLIC SYNDROME | - |
dc.subject.keywordPlus | VISCERAL OBESITY | - |
dc.subject.keywordPlus | TYPE-1 | - |
dc.subject.keywordPlus | MICE | - |
dc.subject.keywordPlus | HYPERGLYCEMIA | - |
dc.subject.keywordPlus | DRUGS | - |
dc.subject.keywordAuthor | Diabetes | - |
dc.subject.keywordAuthor | 11beta-HSD1 | - |
dc.subject.keywordAuthor | Thiazolidine | - |
dc.subject.keywordAuthor | Adamantyl | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.